Dr. Sarah Crome was recently recruited as a Scientist to Toronto General Hospital Research Institute of the University Health Network, and as Assistant Professor of Immunology at the University of Toronto. She will be working within the Multi Organ Transplant Program, where her research will focus on identifying mechanism that control T cell responses, the role of innate lymphoid cells in transplantation, and development of novel immunotherapies. Sarah’s scientific career started in the laboratory of Dr. Megan Levings in the Department of Experimental Medicine at the University of British Columbia. There her research defined molecular, epigenetic and cellular regulatory mechanism that control human CD4+ T helper 17 cell development and their pro-inflammatory functions. Her postdoctoral work in the laboratory of Dr. Pamela Ohashi at Princess Margaret Cancer Centre identified a distinct innate lymphoid cell (ILC) population that inhibits the activity and expansion of T cells, and is associated with poorer clinical outcomes in ovarian cancer. Recently she has been working to define molecular mechanisms controlling ILC-mediated regulation of T cell-induced tissue destruction. Sarah’s is a Medicine by Design Investigator and holds the Cancer Research Society’s Next Generation Scientist award. She is actively recruiting keen graduate students and postdoctoral fellows to join her program.